Mårten Segelmark

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rachel Jones, Jan Willem Cohen Tervaert, Thomas Häuser et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies

Richard Watts, Suzanne Lane, Thomas Hanslik et al. · Annals of the Rheumatic Diseases · 2006 · 1.3K citations · Full text

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

Max Yates, Richard A. Watts, Ingeborg M. Bajema et al. · Annals of the Rheumatic Diseases · 2016 · 1.2K citations · Full text

Genetically Distinct Subsets within ANCA-Associated Vasculitis

Paul Lyons, Tim F. Rayner, Sapna Trivedi et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis

David Jayne, Annette Bruchfeld, Lorraine Harper et al. · Journal of the American Society of Nephrology · 2017 · 590 citations · Full text